Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Tumor-adjacent lung transcriptome as a predictor of recurrence in early-stage lung adenocarcinoma [snRNA-seq]

ABSTRACT: Single nuclei RNA analysis of adjacent normal tissue to predict recurrence in lung cancer patients

ORGANISM(S): Homo sapiens

PROVIDER: GSE229253 | GEO | 2023/09/08

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Tumor-adjacent lung transcriptome as a predictor of recurrence in early-stage lung adenocarcinoma [snRNA-seq]

Project description:Tumor-adjacent lung transcriptome as a predictor of recurrence in early-stage lung adenocarcinoma [snRNA-seq]

| PRJNA953640 | ENA

Tumor-adjacent lung transcriptome as a predictor of recurrence in early-stage lung adenocarcinoma [bulk RNA-seq]

Project description:Tumor-adjacent lung transcriptome as a predictor of recurrence in early-stage lung adenocarcinoma [bulk RNA-seq]

| PRJNA955664 | ENA

Tumor-adjacent lung transcriptome as a predictor of recurrence in early-stage lung adenocarcinoma [bulk RNA-seq]

Project description:Bulk RNA-seq analysis of matched tumor/normal samples

2023-09-08 | GSE229705 | GEO

Generating a robust prediction model for stage I lung adenocarcinoma recurrence after surgical resection

Project description:211 FFPE NSLC surgical samples were used to generate recurrence prediction models

2018-02-13 | GSE90623 | GEO

Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma

Project description:Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma

| PRJNA955661 | ENA

A 50-Gene Predictor of Recurrence as a Guide to Therapy in Early-Stage Colon Cancer.

Project description:Gene expression profiles reflect unique aspects of individual biologic phenotypes and may characterize the heterogeneity of solid tumors. Using previously-described methodologies that employ DNA microarray data, a 50-gene expression profile (metagene) that predicts risk of recurrence in early stage colon carcinoma was identified. This analysis used an initial discovery cohort of 52 patients. The performance of the 50-gene predictor was evaluated in an independent validation cohort of 73 patients. Using a connectivity map analysis of the 50-gene model, we identified candidate agents and then tested the in vitro efficacy of these compounds in colon cancer cell lines. 73 samples that had patient recurrence data with stage information were used in the analysis. Keywords: Disease state analysis

2008-12-03 | GSE10402 | GEO

A 50-Gene Predictor of Recurrence as a Guide to Therapy in Early-Stage Colon Cancer.

2010-05-15 | E-GEOD-10402 | biostudies-arrayexpress

Gene expression analysis of lung adenocarcinoma and adjacent non-tumor tissues

Project description:Genome wide gene expression profiling of lung adenocarcinoma and non-tumor adjacent tissues. The Agilent microarray was used to obtain gene expression profiles. Samples included eight lung cancer and adjacent non-tumor tissues excised from a cohort of 8 patients with lung adenocarcinoma.

2017-03-09 | GSE85841 | GEO

DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues

Project description:Genome wide DNA methylation profiling of lung adenocarcinoma and non-tumor adjacent tissues. The Illumina Infinium 450k Human DNA methylation Beadchip was used to obtain DNA methylation profiles. Samples included eight lung cancer and adjacent non-tumor tissues excised from a cohort of 8 patients with lung adenocarcinoma.

2016-12-01 | GSE85845 | GEO

BACH1: A Potential Predictor of Survival in Early-Stage Lung Adenocarcinoma.

Project description:PurposeRecent researches showed the vital role of BACH1 in promoting the metastasis of lung cancer. We aimed to explore the value of BACH1 in predicting the overall survival (OS) of early-stage (stages I-II) lung adenocarcinoma. Patients and Methods. Lung adenocarcinoma cases were screened from the Cancer Genome Atlas (TCGA) database. Functional enrichment analysis was performed to obtain the biological mechanisms of BACH1. Gene set enrichment analysis (GSEA) was performed to identify the difference of biological pathways between high- and low-BACH1 groups. Univariate and multivariate COX regression analysis had been used to screen prognostic factors, which were used to establish the BACH1 expression-based prognostic model in the TCGA dataset. The C-index and time-dependent AUC curve were used to evaluate predictive power of the model. External validation of prognostic value was performed in two independent datasets from Gene Expression Omnibus (GEO). Decision analysis curve was finally used to evaluate clinical usefulness of the BACH1-based model beyond pathologic stage alone.ResultsBACH1 was an independent prognostic factor for lung adenocarcinoma. High-expression BACH1 cases had worse OS. BACH1-based prognostic model showed an ideal C-index and t-AUC and validated by two GEO datasets, independently. More importantly, the BACH1-based model indicated positive clinical applicability by DCA curves.ConclusionOur research confirmed that BACH1 was an important predictor of prognosis in early-stage lung adenocarcinoma. The higher the expression of BACH1, the worse OS of the patients.

| S-EPMC8758312 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data